Maldonado-Soto Angel R, Oakley Derek H, Wichterle Hynek, Stein Joel, Doetsch Fiona K, Henderson Christopher E
From the Columbia Stem Cell Initiative (ARM-S, DHO, HW, JS, FKD, CEH); Departments of Pathology and Cell Biology, Neurology and Neuroscience, Center for Motor Neuron Biology and Disease (ARM-S, DHO, HW, FKD, CEH); Project A.L.S./Jenifer Estess Laboratory for Stem Cell Research (DHO, HW, CEH); and Department of Rehabilitation and Regenerative Medicine (ARM-S, JS, FKD, CEH), Columbia University Medical Center, New York, New York.
Am J Phys Med Rehabil. 2014 Nov;93(11 Suppl 3):S132-44. doi: 10.1097/PHM.0000000000000111.
Given their capacity to regenerate cells lost through injury or disease, stem cells offer new vistas into possible treatments for degenerative diseases and their underlying causes. As such, stem cell biology is emerging as a driving force behind many studies in regenerative medicine. This review focuses on the current understanding of the applications of stem cells in treating ailments of the human brain, with an emphasis on neurodegenerative diseases. Two types of neural stem cells are discussed: endogenous neural stem cells residing within the adult brain and pluripotent stem cells capable of forming neural cells in culture. Endogenous neural stem cells give rise to neurons throughout life, but they are restricted to specialized regions in the brain. Elucidating the molecular mechanisms regulating these cells is key in determining their therapeutic potential as well as finding mechanisms to activate dormant stem cells outside these specialized microdomains. In parallel, patient-derived stem cells can be used to generate neural cells in culture, providing new tools for disease modeling, drug testing, and cell-based therapies. Turning these technologies into viable treatments will require the integration of basic science with clinical skills in rehabilitation.
鉴于干细胞具有再生因损伤或疾病而丢失的细胞的能力,它们为退行性疾病及其潜在病因的可能治疗方法提供了新的前景。因此,干细胞生物学正在成为再生医学许多研究背后的驱动力。本综述重点关注目前对干细胞在治疗人类脑部疾病中的应用的理解,尤其侧重于神经退行性疾病。文中讨论了两种类型的神经干细胞:存在于成体大脑中的内源性神经干细胞以及能够在培养中形成神经细胞的多能干细胞。内源性神经干细胞在整个生命过程中都能产生神经元,但它们局限于大脑中的特定区域。阐明调节这些细胞的分子机制是确定它们的治疗潜力以及找到激活这些特殊微环境之外休眠干细胞的机制的关键。与此同时,患者来源的干细胞可用于在培养中生成神经细胞,为疾病建模、药物测试和基于细胞的治疗提供新工具。将这些技术转化为可行的治疗方法需要基础科学与康复临床技能的整合。